Longitudinal Myelitis As The First Manifestation of Systemic Lupus Erythematosus

Basit Öğe Kaydı
dc.contributor.authorCelebisoy, Nese
dc.contributor.authorGulec, Feray
dc.contributor.authorBayrakci, Adem
dc.contributor.authorYargucu, Figen
dc.date.accessioned2019-10-27T20:21:11Z
dc.date.available2019-10-27T20:21:11Z
dc.date.issued2009
dc.departmentEge Üniversitesien_US
dc.description.abstractAcute longitudinal myelitis (ALM) as the initial manifestation of systemic lupus erythematosus (SLE) has been reported in just two cases. We herein present the third case associated with antiphospholipid antibodies with an unfavorable outcome. All patients with ALM should be tested for SLE and urgent treatment with intravenous pulse methylprednisolone and cyclophosphamide must be started. Alternative treatment trials must also be established as there are patients with permanent neurologic disability like ours despite appropriate therapy.en_US
dc.identifier.endpage494en_US
dc.identifier.issn1302-1664
dc.identifier.issue4en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage492en_US
dc.identifier.urihttps://hdl.handle.net/11454/41727
dc.identifier.volume26en_US
dc.identifier.wosWOS:000273393300014en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.publisherJournal Neurological Sciencesen_US
dc.relation.ispartofJournal of Neurological Sciences-Turkishen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectLongitudinal myelitisen_US
dc.subjectsystemic lupus erythematosusen_US
dc.subjectantiphospholipid antibodiesen_US
dc.titleLongitudinal Myelitis As The First Manifestation of Systemic Lupus Erythematosusen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu